Sunitinib is an antineoplastic agent used to treat advanced renal cell carcinoma and gastrointestinal stromal tumors. It works by inhibiting multiple receptor tyrosine kinases involved in tumor growth and angiogenesis. Sunitinib is effective in managing specific cancer types. In summary, it plays a vital role in targeted cancer therapy.
Sunitinib inhibits receptor tyrosine kinases, preventing tumor cell proliferation and angiogenesis.
No published brands for this salt yet.